NYSE:PKI - PerkinElmer Stock Price, Price Target & More

$74.60 -0.50 (-0.67 %)
(As of 04/20/2018 04:00 PM ET)
Previous Close$74.60
Today's Range$74.28 - $75.47
52-Week Range$56.98 - $84.49
Volume501,261 shs
Average Volume601,335 shs
Market Capitalization$8.30 billion
P/E Ratio25.72
Dividend Yield0.37%
Beta0.81

About PerkinElmer (NYSE:PKI)

PerkinElmer logoPerkinElmer, Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, food, and laboratory services markets worldwide. The company operates in two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment develops and offers analytical technologies, solutions, and services for the environmental market that enable its customers to understand the characterization and health of various aspects, including air, water, and soil. It also provides solutions to farmers and food producers; an analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries; and laboratory services. In addition, this segment offers a suite of solutions comprising reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market. The Diagnostics segment provides instruments, reagents, and software test and screen products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used in diagnosing genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for use in applications covering oncology, genetic testing, and drug discovery. The company serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1931 and is headquartered in Waltham, Massachusetts.

Receive PKI News and Ratings via Email

Sign-up to receive the latest news and ratings for PKI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
SymbolNYSE:PKI
CUSIP71404610
Phone781-663-6900

Debt

Debt-to-Equity Ratio0.71%
Current Ratio1.26%
Quick Ratio0.89%

Price-To-Earnings

Trailing P/E Ratio25.72
Forward P/E Ratio21.19
P/E Growth2.08

Sales & Book Value

Annual Sales$2.26 billion
Price / Sales3.65
Cash Flow$3.8976 per share
Price / Cash19.14
Book Value$22.71 per share
Price / Book3.28

Profitability

EPS (Most Recent Fiscal Year)$2.90
Net Income$292.63 million
Net Margins12.97%
Return on Equity13.30%
Return on Assets6.51%

Miscellaneous

Employees11,000
Outstanding Shares110,500,000

How to Become a New Pot Stock Millionaire

PerkinElmer (NYSE:PKI) Frequently Asked Questions

What is PerkinElmer's stock symbol?

PerkinElmer trades on the New York Stock Exchange (NYSE) under the ticker symbol "PKI."

How often does PerkinElmer pay dividends? What is the dividend yield for PerkinElmer?

PerkinElmer announced a quarterly dividend on Friday, January 26th. Stockholders of record on Friday, April 13th will be paid a dividend of $0.07 per share on Thursday, May 10th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.38%. The ex-dividend date is Thursday, April 12th. View PerkinElmer's Dividend History.

How were PerkinElmer's earnings last quarter?

PerkinElmer (NYSE:PKI) announced its quarterly earnings data on Thursday, January, 25th. The medical research company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.94 by $0.03. The medical research company had revenue of $641.63 million for the quarter, compared to analyst estimates of $619.14 million. PerkinElmer had a net margin of 12.97% and a return on equity of 13.30%. PerkinElmer's revenue was up 13.2% compared to the same quarter last year. During the same period in the prior year, the company posted $0.83 EPS. View PerkinElmer's Earnings History.

When is PerkinElmer's next earnings date?

PerkinElmer is scheduled to release their next quarterly earnings announcement on Monday, April, 30th 2018. View Earnings Estimates for PerkinElmer.

What guidance has PerkinElmer issued on next quarter's earnings?

PerkinElmer issued an update on its FY18 earnings guidance on Thursday, January, 25th. The company provided EPS guidance of approx $3.50 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.47.

What price target have analysts set for PKI?

13 brokers have issued 1 year price objectives for PerkinElmer's shares. Their forecasts range from $65.00 to $88.00. On average, they expect PerkinElmer's stock price to reach $76.9231 in the next year. View Analyst Ratings for PerkinElmer.

What are Wall Street analysts saying about PerkinElmer stock?

Here are some recent quotes from research analysts about PerkinElmer stock:
  • 1. According to Zacks Investment Research, "PerkinElmer outperformed its industry in the past year. A number of product launches resulted in solid organic revenue growth for the company. Furthermore, a positive guidance instills our confidence in the stock. PerkinElmer’s strong global foothold is noteworthy, courtesy of its acquisition of Germany-based EUROIMMUN and India-based Tulip Diagnostics. EUROIMMUN acquisition has significantly expanded PerkinElmer’s reach into autoimmune and allergy diagnostic markets. With an enhanced focus on product innovation, PerkinElmer has considerable potential upside. On the flipside, despite having a diversified portfolio, unfavorable foreign exchange is a primary concern. PerkinElmer continues to acquire a large number of companies which adds integration risks. Also, high debt levels may hinder the company’s expansion plans." (3/20/2018)
  • 2. Cantor Fitzgerald analysts commented, "Newborn screening in China continues to drive strong diagnostic growth, despite a slight decline in the Haoyuan nucleic acid testing. Diagnostic revenue in China was up more than 20% y/y in 1Q17. Despite a slight moderation in birth rates, uptake of the automated Genetic Screening Processor (GSP) has driven menu expansion. The company reports that 20-25% of the market is now screening for ~20 disorders, while the remaining 80% is screening for 2-4 disorders. India, the largest newborn screening opportunity with an estimated 26M annual births, continues to be relatively unpenetrated, but we do not anticipate a steep adoption ramp as the company experienced in China. Increase in reported revenue guidance leaves organic growth unchanged. The company raised its 2017 revenue guidance to $2.200-2.220B from $2.19-2.20B, implying 4-5% y/y reported revenue growth, compared with our prior estimate of $2.199B. Notably, the 4% organic revenue growth rate is unchanged, and the company expects a slightly lower FX headwind for 2017." (5/5/2017)

Who are some of PerkinElmer's key competitors?

Who are PerkinElmer's key executives?

PerkinElmer's management team includes the folowing people:
  • Mr. Robert F. Friel, Chairman, CEO & Pres (Age 62)
  • Mr. Frank A. Wilson, Sr. VP & CFO (Age 59)
  • Mr. Joel S. Goldberg, Sr. VP of Admin., Gen. Counsel & Sec. (Age 49)
  • Mr. James Corbett, Exec. VP & Pres of Discovery and Analytical Solutions (Age 55)
  • Mr. Prahlad R. Singh, Exec. VP & Pres of Diagnostics (Age 53)

Has PerkinElmer been receiving favorable news coverage?

Headlines about PKI stock have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research group identifies negative and positive media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. PerkinElmer earned a news sentiment score of 0.13 on Accern's scale. They also assigned press coverage about the medical research company an impact score of 46.88 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

How do I buy shares of PerkinElmer?

Shares of PKI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is PerkinElmer's stock price today?

One share of PKI stock can currently be purchased for approximately $74.60.

How big of a company is PerkinElmer?

PerkinElmer has a market capitalization of $8.30 billion and generates $2.26 billion in revenue each year. The medical research company earns $292.63 million in net income (profit) each year or $2.90 on an earnings per share basis. PerkinElmer employs 11,000 workers across the globe.

How can I contact PerkinElmer?

PerkinElmer's mailing address is 940 WINTER STREET, WALTHAM MA, 02451. The medical research company can be reached via phone at 781-663-6900 or via email at [email protected]


MarketBeat Community Rating for PerkinElmer (PKI)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  324 (Vote Outperform)
Underperform Votes:  333 (Vote Underperform)
Total Votes:  657
MarketBeat's community ratings are surveys of what our community members think about PerkinElmer and other stocks. Vote "Outperform" if you believe PKI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PKI will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

PerkinElmer (NYSE:PKI) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
13 Wall Street analysts have issued ratings and price targets for PerkinElmer in the last 12 months. Their average twelve-month price target is $76.9231, suggesting that the stock has a possible upside of 3.11%. The high price target for PKI is $88.00 and the low price target for PKI is $65.00. There are currently 1 sell rating, 8 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.232.312.292.20
Ratings Breakdown: 1 Sell Rating(s)
8 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
7 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
8 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
8 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $76.9231$76.0833$72.5833$67.6923
Price Target Upside: 3.11% upside8.06% downside4.70% downside5.63% downside

PerkinElmer (NYSE:PKI) Consensus Price Target History

Price Target History for PerkinElmer (NYSE:PKI)

PerkinElmer (NYSE:PKI) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/11/2018Morgan StanleyLower Price TargetOverweight -> Overweight$89.00 -> $85.00LowView Rating Details
4/9/2018Deutsche BankLower Price TargetHold -> Hold$85.00 -> $80.00LowView Rating Details
1/26/2018BarclaysBoost Price TargetUnderweight -> Underweight$69.00 -> $73.00LowView Rating Details
1/26/2018CowenReiterated RatingHold$84.00LowView Rating Details
1/26/2018Robert W. BairdReiterated RatingBuy$88.00MediumView Rating Details
1/3/2018Evercore ISIInitiated CoverageIn-Line$77.00LowView Rating Details
12/19/2017Bank of AmericaUpgradeUnderperform -> Neutral$78.00LowView Rating Details
10/20/2017Jefferies GroupReiterated RatingHold$70.00N/AView Rating Details
9/26/2017Goldman SachsReiterated RatingNeutral -> Neutral$67.00LowView Rating Details
9/26/2017CitigroupReiterated RatingBuy$74.00 -> $80.00LowView Rating Details
8/4/2017Piper JaffrayReiterated RatingBuy$81.00MediumView Rating Details
7/16/2017Cantor FitzgeraldReiterated RatingHoldLowView Rating Details
7/13/2017Wells FargoInitiated CoverageMarket Perform -> Market Perform$72.00LowView Rating Details
3/27/2017Janney Montgomery ScottUpgradeNeutral -> BuyMediumView Rating Details
2/5/2017BTIG ResearchReiterated RatingHoldN/AView Rating Details
9/22/2016UBSReiterated RatingBuy$56.00 -> $61.00N/AView Rating Details
8/5/2016JPMorgan ChaseBoost Price TargetNeutral$52.00 -> $55.00N/AView Rating Details
8/5/2016MizuhoDowngradeBuy -> Neutral$56.00N/AView Rating Details
5/6/2016Stifel NicolausBoost Price TargetBuy$51.00 -> $59.00N/AView Rating Details
(Data available from 4/21/2016 forward)

Earnings

PerkinElmer (NYSE:PKI) Earnings History and Estimates Chart

Earnings by Quarter for PerkinElmer (NYSE:PKI)

PerkinElmer (NYSE:PKI) Earnings Estimates

2018 EPS Consensus Estimate: $3.53
2019 EPS Consensus Estimate: $4.01
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.61$0.61$0.61
Q2 20181$0.85$0.85$0.85
Q3 20181$0.91$0.91$0.91
Q4 20181$1.16$1.16$1.16
Q1 20191$0.89$0.89$0.89
Q2 20191$0.99$0.99$0.99
Q3 20191$0.99$0.99$0.99
Q4 20191$1.14$1.14$1.14

PerkinElmer (NYSE PKI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2018$0.62N/AView Earnings Details
1/25/2018Q4 2017$0.94$0.97$619.14 million$641.63 millionViewN/AView Earnings Details
11/2/2017Q3 2017$0.72$0.73$552.38 million$554.28 millionViewN/AView Earnings Details
8/3/2017Q2 2017$0.67$0.67$554.14 million$547.00 millionViewListenView Earnings Details
5/4/2017Q1 2017$0.54$0.55$506.81 million$514.12 millionViewListenView Earnings Details
2/2/2017Q4 2016$0.86$0.83$613.15 million$566.77 millionViewN/AView Earnings Details
11/7/2016Q3$0.66$0.68$572.03 million$548.00 millionViewListenView Earnings Details
8/4/2016Q2 2016$0.66$0.67$573.31 million$572.67 millionViewN/AView Earnings Details
5/5/2016Q116$0.51$0.56$532.55 million$538.70 millionViewN/AView Earnings Details
2/4/2016Q4 2015$0.87$0.86$616.70 million$608.12 millionViewN/AView Earnings Details
11/5/2015Q315$0.60$0.60$554.88 million$563.00 millionViewN/AView Earnings Details
7/30/2015Q2$0.59$0.60$555.66 million$564.00 millionViewListenView Earnings Details
4/30/2015Q115$0.46$0.50$537.27 million$526.90 millionViewN/AView Earnings Details
1/29/2015Q414$0.78$0.85$602.35 million$608.60 millionViewN/AView Earnings Details
10/30/2014Q3$0.57$0.67$550.40 million$542.05 millionViewListenView Earnings Details
8/7/2014Q2$0.59$0.59$572.26 million$556.20 millionViewListenView Earnings Details
4/24/2014Q114$0.44$0.46$531.31 million$531.90 millionViewListenView Earnings Details
1/30/2014Q413$0.70$0.73$588.95 million$594.00 millionViewListenView Earnings Details
10/30/2013Q313$0.48$0.49$523.84 million$524.30 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.48$0.51$532.95 million$543.30 millionViewListenView Earnings Details
4/25/2013Q1 2013$0.48$0.36$532.25 million$505.38 millionViewListenView Earnings Details
1/31/2013Q4 2012$0.65$0.65$577.94 million$577.00 millionViewListenView Earnings Details
10/25/2012$0.44$0.45ViewN/AView Earnings Details
8/2/2012$0.47$0.53ViewN/AView Earnings Details
4/26/2012$0.41$0.43ViewN/AView Earnings Details
2/2/2012$0.51$0.62ViewN/AView Earnings Details
11/3/2011$0.39$0.41ViewN/AView Earnings Details
8/4/2011$0.40$0.42ViewN/AView Earnings Details
5/5/2011$0.31$0.34ViewN/AView Earnings Details
2/3/2011$0.41$0.44ViewN/AView Earnings Details
11/4/2010Q3 2010$0.29$0.31ViewN/AView Earnings Details
8/5/2010Q2 2010$0.33$0.38ViewN/AView Earnings Details
5/6/2010Q1 2010$0.29$0.31ViewN/AView Earnings Details
2/4/2010Q4 2009$0.41$0.43ViewN/AView Earnings Details
10/29/2009Q3 2009$0.27$0.30ViewN/AView Earnings Details
7/30/2009Q2 2009$0.26$0.28ViewN/AView Earnings Details
4/30/2009Q1 2009$0.20$0.26ViewN/AView Earnings Details
1/29/2009Q4 2008$0.42$0.46ViewN/AView Earnings Details
10/23/2008Q3 2008$0.36$0.37ViewN/AView Earnings Details
7/24/2008Q2 2008$0.34$0.35ViewN/AView Earnings Details
4/24/2008Q1 2008$0.25$0.28ViewN/AView Earnings Details
1/24/2008Q4 2007$0.42$0.45ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

PerkinElmer (NYSE:PKI) Dividend Information

PerkinElmer pays an annual dividend of $0.28 per share, with a dividend yield of 0.38%. PKI's next quarterly dividend payment will be made on Thursday, May 10. PerkinElmer pays out 9.66% of its earnings out as a dividend.
Next Dividend:5/10/2018
Annual Dividend:$0.28
Dividend Yield:0.38%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:9.66% (Trailing 12 Months of Earnings)
7.95% (Based on This Year's Estimates)
7.02% (Based on Next Year's Estimates)
Frequency:Quarterly Dividend
Dividend Payments by Quarter for PerkinElmer (NYSE:PKI)

PerkinElmer (NYSE:PKI) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/26/2018quarterly$0.070.37%4/12/20184/13/20185/10/2018
10/27/2017quarterly$0.070.39%1/18/20181/19/20182/9/2018
7/24/2017quarterly$0.070.41%10/19/201710/20/201711/10/2017
4/28/2017quarterly$0.070.47%7/19/20177/21/20178/10/2017
1/27/2017quarterly$0.070.54%4/11/20174/14/20175/10/2017
10/26/2016quarterly$0.070.55%1/18/20171/20/20172/10/2017
7/27/2016quarterly$0.070.5%10/12/201610/14/201611/10/2016
4/25/2016quarterly$0.070.55%7/13/20167/15/20168/10/2016
1/28/2016quarterly$0.070.58%4/13/20164/15/20165/10/2016
10/29/2015quarterly$0.070.54%1/13/20161/15/20162/10/2016
7/23/2015quarterly$0.070.55%10/14/201510/16/201511/10/2015
4/27/2015quarterly$0.070.54%7/15/20157/17/20158/10/2015
1/23/2015quarterly$0.070.63%4/15/20154/17/20155/11/2015
10/23/2014quarterly$0.070.67%1/14/20151/16/20152/6/2015
7/24/2014quarterly$0.070.59%10/15/201410/17/201411/7/2014
4/22/2014quarterly$0.070.63%7/16/20147/18/20148/8/2014
1/24/2014quarterly$0.070.68%4/15/20144/18/20145/9/2014
10/24/2013quarterly$0.070.73%1/15/20141/17/20142/7/2014
7/26/2013quarterly$0.070.82%10/16/201310/18/201311/8/2013
6/13/2013quarterly$0.070.85%7/17/20137/19/20138/9/2013
1/25/2013quarterly$0.070.79%4/17/20134/19/20135/10/2013
(Data available from 1/1/2013 forward)

Insider Trades

PerkinElmer (NYSE PKI) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.10%
Institutional Ownership Percentage: 91.93%
Insider Trading History for PerkinElmer (NYSE:PKI)
Institutional Ownership by Quarter for PerkinElmer (NYSE:PKI)

PerkinElmer (NYSE PKI) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/18/2018Daniel R TereauInsiderSell1,156$77.00$89,012.006,784View SEC Filing  
3/5/2018Frank Anders WilsonInsiderSell103,656$73.94$7,664,324.6493,624View SEC Filing  
2/8/2018Andrew OkunInsiderSell2,324$75.44$175,322.568,876View SEC Filing  
2/5/2018Andrew OkunInsiderSell2,273$77.86$176,975.78View SEC Filing  
12/15/2017Andrew OkunInsiderSell12,680$72.00$912,960.0025,121View SEC Filing  
12/7/2017Frank Anders WilsonInsiderSell37,535$70.14$2,632,704.90View SEC Filing  
11/30/2017Alexis P MichasDirectorSell5,000$73.18$365,900.00View SEC Filing  
11/13/2017Peter BarrettDirectorSell7,071$71.07$502,535.9726,271View SEC Filing  
11/7/2017Nicholas A LopardoDirectorSell24,050$70.72$1,700,816.00View SEC Filing  
6/19/2017Andrew OkunInsiderSell4,358$65.00$283,270.0016,799View SEC Filing  
6/1/2017Peter BarrettDirectorSell10,000$63.22$632,200.0029,200View SEC Filing  
5/15/2017Patrick J SullivanDirectorSell6,628$62.59$414,846.5242,951View SEC Filing  
5/4/2017Robert F FrielInsiderSell25,100$60.00$1,506,000.00597,071View SEC Filing  
4/27/2017Robert F FrielInsiderSell124,837$60.11$7,503,952.07696,810View SEC Filing  
3/20/2017Andrew OkunInsiderSell3,000$57.27$171,810.0012,441View SEC Filing  
3/13/2017Joel S GoldbergInsiderSell30,710$55.45$1,702,869.5091,768View SEC Filing  
2/21/2017Alexis P. MichasDirectorSell8,308$55.60$461,924.80View SEC Filing  
2/15/2017Prahlad R SinghInsiderSell9,576$55.00$526,680.0016,319View SEC Filing  
2/9/2017Daniel R TereauInsiderSell5,001$53.16$265,853.1612,147View SEC Filing  
2/9/2017Vicki L SatoDirectorSell8,308$54.01$448,715.0838,278View SEC Filing  
2/6/2017Daniel R TereauInsiderSell4,069$52.01$211,628.699,465View SEC Filing  
12/1/2016Alexis P. MichasDirectorSell15,000$51.00$765,000.00View SEC Filing  
9/22/2016Joel S GoldbergInsiderSell38,095$55.00$2,095,225.0096,299View SEC Filing  
9/12/2016Daniel R TereauInsiderSell18,866$52.00$981,032.0021,241View SEC Filing  
8/24/2016Kenton J SicchitanoDirectorSell15,189$54.87$833,420.4343,160View SEC Filing  
8/17/2016Patrick J SullivanDirectorSell8,308$54.74$454,779.9241,829View SEC Filing  
6/2/2016Alexis P MichasDirectorSell1,953$54.85$107,122.0568,290View SEC Filing  
5/24/2016Robert F FrielCEOSell128,300$55.01$7,057,783.00690,831View SEC Filing  
5/16/2016Robert F FrielCEOSell109,000$55.01$5,996,090.00569,953View SEC Filing  
5/11/2016Robert F FrielCEOSell10,685$55.01$587,781.85573,216View SEC Filing  
5/10/2016Vicki L SatoDirectorSell12,586$54.51$686,062.8636,960View SEC Filing  
5/6/2016Robert F FrielCEOSell4,116$55.00$226,380.00566,647View SEC Filing  
4/18/2016Daniel R TereauInsiderSell2,158$50.79$109,604.828,602View SEC Filing  
3/21/2016James CorbettInsiderSell1,723$48.74$83,979.0228,881View SEC Filing  
2/24/2016Alexis P. MichasDirectorSell10,000$47.56$475,600.00View SEC Filing  
12/3/2015Kenton J SicchitanoDirectorSell10,216$51.05$521,526.8031,658View SEC Filing  
11/3/2015Frank Anders WilsoninsiderSell16,380$52.69$863,062.2055,859View SEC Filing  
10/23/2015Andrew OkunInsiderSell2,000$50.00$100,000.0011,278View SEC Filing  
9/14/2015James CorbettInsiderSell3,000$47.59$142,770.0021,664View SEC Filing  
9/3/2015Kenton J. SicchitanoDirectorSell12,586$47.88$602,617.6841,874View SEC Filing  
6/5/2015Alexis P MichasDirectorSell20,000$52.25$1,045,000.00View SEC Filing  
6/3/2015Frank Anders WilsonInsiderSell16,380$52.60$861,588.00View SEC Filing  
3/27/2015Joel S GoldbergInsiderSell10,646$51.00$542,946.00View SEC Filing  
3/23/2015Andrew OkunInsiderSell2,000$50.09$100,180.00View SEC Filing  
3/20/2015James CorbettInsiderSell5,157$50.23$259,036.11View SEC Filing  
3/18/2015Joel S GoldbergInsiderSell9,000$49.00$441,000.00View SEC Filing  
3/6/2015Patrick J SullivanDirectorSell12,586$46.90$590,283.40View SEC Filing  
3/5/2015Alexis P MichasDirectorSell8,892$47.00$417,924.00View SEC Filing  
3/5/2015Joel S GoldbergInsiderSell9,000$47.00$423,000.00View SEC Filing  
2/10/2015Vicki L SatoDirectorSell24,000$45.55$1,093,200.00View SEC Filing  
2/9/2015Andrew OkunInsiderSell6,262$45.82$286,924.84View SEC Filing  
2/3/2015Nicholas A LopardoDirectorSell8,892$46.30$411,699.60View SEC Filing  
2/3/2015Robert F FrielCEOSell60,709$46.26$2,808,398.34View SEC Filing  
2/2/2015Robert F FrielCEOSell319,065$46.02$14,683,371.30View SEC Filing  
11/14/2014James C MullenDirectorSell8,892$43.73$388,847.16View SEC Filing  
11/13/2014Patrick J SullivanDirectorSell8,892$43.46$386,446.32View SEC Filing  
9/4/2014Kenton J SicchitanoDirectorSell8,892$44.98$399,962.16View SEC Filing  
7/2/2014Daniel R MarshakSVPSell12,000$48.00$576,000.00View SEC Filing  
6/26/2014Daniel R MarshakSVPSell10,000$46.60$466,000.00View SEC Filing  
6/19/2014James CorbettInsiderSell57,126$46.69$2,667,212.94View SEC Filing  
6/9/2014Maurice H TenneyInsiderSell5,504$47.26$260,119.04View SEC Filing  
6/9/2014Robert F FrielCEOSell124,858$46.70$5,830,868.60View SEC Filing  
6/5/2014Alexis P MichasDirectorSell9,146$46.30$423,459.80View SEC Filing  
6/2/2014Alexis P MichasDirectorSell5,854$45.00$263,430.00View SEC Filing  
6/2/2014Joel S GoldbergInsiderSell17,000$45.11$766,870.00View SEC Filing  
5/12/2014Alexis MichasDirectorSell5,000$44.40$222,000.0096,321View SEC Filing  
4/29/2014Nicholas LopardoDirectorSell12,951$41.98$543,682.9878,622View SEC Filing  
4/7/2014James CorbettInsiderSell22,027$45.11$993,637.9721,858View SEC Filing  
3/12/2014Daniel MarshakSVPSell19,292$45.29$873,734.6845,445View SEC Filing  
3/11/2014John LetcherSVPSell41,000$45.40$1,861,400.0034,514View SEC Filing  
3/7/2014Andrew OkunCAOSell9,398$46.35$435,597.3013,816View SEC Filing  
2/27/2014Alexis MichasDirectorSell5,000$45.25$226,250.0095,067View SEC Filing  
2/14/2014Vicki SatoDirectorSell21,843$43.97$960,436.7145,370View SEC Filing  
2/7/2014James MullenDirectorSell12,951$43.73$566,347.2343,178View SEC Filing  
12/13/2013Maurice TenneyInsiderSell25,000$38.91$972,750.0026,109View SEC Filing  
12/10/2013Daniel MarshakSVPSell12,183$39.59$482,324.9742,762View SEC Filing  
11/14/2013Robert FrielCEOSell112,461$37.14$4,176,801.54516,849View SEC Filing  
9/10/2013Robert F FrielCEOSell141,000$37.45$5,280,450.00View SEC Filing  
9/6/2013Andrew OkunCAOSell6,805$36.86$250,832.30View SEC Filing  
5/1/2013Alexis P MichasDirectorSell6,440$30.85$198,674.00View SEC Filing  
4/30/2013James C MullenDirectorSell6,440$30.31$195,196.40View SEC Filing  
4/11/2013Maurice H TenneyInsiderSell9,500$35.00$332,500.00View SEC Filing  
9/13/2012Robert F FrielCEOSell50,565$29.00$1,466,385.00View SEC Filing  
8/9/2012Kenton J SicchitanoDirectorSell9,454$27.93$264,050.22View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

PerkinElmer (NYSE PKI) News Headlines

Source:
DateHeadline
PerkinElmer (PKI) Stock Rating Reaffirmed by CowenPerkinElmer (PKI) Stock Rating Reaffirmed by Cowen
www.americanbankingnews.com - April 20 at 8:01 PM
PerkinElmers (PKI) Hold Rating Reaffirmed at Jefferies GroupPerkinElmer's (PKI) Hold Rating Reaffirmed at Jefferies Group
www.americanbankingnews.com - April 20 at 7:28 PM
PerkinElmer (PKI) Insider Sells $89,012.00 in StockPerkinElmer (PKI) Insider Sells $89,012.00 in Stock
www.americanbankingnews.com - April 19 at 7:53 PM
Can Diagnostic Revenues Drive PerkinElmer (PKI) Q1 Earnings?Can Diagnostic Revenues Drive PerkinElmer (PKI) Q1 Earnings?
finance.yahoo.com - April 19 at 5:55 PM
PerkinElmer (PKI) Now Covered by Analysts at Wells FargoPerkinElmer (PKI) Now Covered by Analysts at Wells Fargo
www.americanbankingnews.com - April 18 at 1:56 PM
Q1 2018 EPS Estimates for PerkinElmer Boosted by Analyst (PKI)Q1 2018 EPS Estimates for PerkinElmer Boosted by Analyst (PKI)
www.americanbankingnews.com - April 18 at 7:52 AM
PerkinElmer (PKI) Expected to Post Quarterly Sales of $615.86 MillionPerkinElmer (PKI) Expected to Post Quarterly Sales of $615.86 Million
www.americanbankingnews.com - April 18 at 2:46 AM
Q3 2018 EPS Estimates for PerkinElmer (PKI) Boosted by Jefferies GroupQ3 2018 EPS Estimates for PerkinElmer (PKI) Boosted by Jefferies Group
www.americanbankingnews.com - April 17 at 6:40 AM
 Brokerages Anticipate PerkinElmer (PKI) Will Post Earnings of $0.61 Per Share Brokerages Anticipate PerkinElmer (PKI) Will Post Earnings of $0.61 Per Share
www.americanbankingnews.com - April 16 at 3:14 PM
New finance chief at PerkinElmerNew finance chief at PerkinElmer
seekingalpha.com - April 11 at 5:53 PM
PerkinElmer teams up with Helix to develop new molecular tests for consumersPerkinElmer teams up with Helix to develop new molecular tests for consumers
seekingalpha.com - April 11 at 5:53 PM
PerkinElmer (PKI) PT Lowered to $85.00PerkinElmer (PKI) PT Lowered to $85.00
www.americanbankingnews.com - April 11 at 9:23 AM
PerkinElmer Collaborates with Helix to Drive Innovation in Exome-Based Personal GenomicsPerkinElmer Collaborates with Helix to Drive Innovation in Exome-Based Personal Genomics
finance.yahoo.com - April 10 at 5:46 PM
PerkinElmer Appoints James Mock as Chief Financial OfficerPerkinElmer Appoints James Mock as Chief Financial Officer
finance.yahoo.com - April 10 at 5:46 PM
PerkinElmer (PKI) and Integra lifesciences (IART) Critical SurveyPerkinElmer (PKI) and Integra lifesciences (IART) Critical Survey
www.americanbankingnews.com - April 10 at 5:13 AM
PerkinElmer (PKI) PT Lowered to $80 at Deutsche BankPerkinElmer (PKI) PT Lowered to $80 at Deutsche Bank
www.streetinsider.com - April 9 at 5:37 PM
Deutsche Bank Lowers PerkinElmer (PKI) Price Target to $80.00Deutsche Bank Lowers PerkinElmer (PKI) Price Target to $80.00
www.americanbankingnews.com - April 9 at 8:50 AM
PerkinElmer to Hold Earnings Call on Monday, April 30, 2018PerkinElmer to Hold Earnings Call on Monday, April 30, 2018
finance.yahoo.com - April 6 at 5:56 PM
BRIEF-PerkinElmer Prices Offering Of Euro Denominated Senior NotesBRIEF-PerkinElmer Prices Offering Of Euro Denominated Senior Notes
www.reuters.com - April 5 at 9:46 AM
Parent Project Muscular Dystrophy Selects PerkinElmer to Support Decode Duchenne ProgramParent Project Muscular Dystrophy Selects PerkinElmer to Support Decode Duchenne Program
www.businesswire.com - April 5 at 9:46 AM
PerkinElmer prices euro debt offeringPerkinElmer prices euro debt offering
seekingalpha.com - April 5 at 9:46 AM
Contrasting PerkinElmer (PKI) & Bio-Rad Laboratories (BIO)Contrasting PerkinElmer (PKI) & Bio-Rad Laboratories (BIO)
www.americanbankingnews.com - April 5 at 1:34 AM
PerkinElmer Prices Offering of Euro-Denominated Senior NotesPerkinElmer Prices Offering of Euro-Denominated Senior Notes
finance.yahoo.com - April 4 at 4:29 PM
PerkinElmer, Inc. -- Moodys rates PerkinElmers senior unsecured euro notes Baa3PerkinElmer, Inc. -- Moody's rates PerkinElmer's senior unsecured euro notes Baa3
finance.yahoo.com - April 4 at 4:29 PM
PerkinElmer (PKI) Upgraded to "Buy" by ValuEnginePerkinElmer (PKI) Upgraded to "Buy" by ValuEngine
www.americanbankingnews.com - April 3 at 10:55 AM
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating PerkinElmer, Inc. for Potential Breaches Of ...SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating PerkinElmer, Inc. for Potential Breaches Of ...
www.prnewswire.com - April 3 at 8:03 AM
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating PerkinElmer, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of DirectorsSHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating PerkinElmer, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
finance.yahoo.com - April 3 at 8:03 AM
PerkinElmer (PKI) Given Consensus Recommendation of "Hold" by AnalystsPerkinElmer (PKI) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - April 1 at 9:37 AM
PerkinElmer (PKI) Expected to Post Quarterly Sales of $616.02 MillionPerkinElmer (PKI) Expected to Post Quarterly Sales of $616.02 Million
www.americanbankingnews.com - April 1 at 2:34 AM
 Brokerages Expect PerkinElmer (PKI) Will Post Earnings of $0.61 Per Share Brokerages Expect PerkinElmer (PKI) Will Post Earnings of $0.61 Per Share
www.americanbankingnews.com - March 30 at 5:14 PM
Contrasting PerkinElmer (PKI) & Entegris (ENTG)Contrasting PerkinElmer (PKI) & Entegris (ENTG)
www.americanbankingnews.com - March 30 at 3:30 PM
Financial Analysis: PerkinElmer (PKI) vs. Taiwan Semiconductor Mfg. (TSM)Financial Analysis: PerkinElmer (PKI) vs. Taiwan Semiconductor Mfg. (TSM)
www.americanbankingnews.com - March 24 at 5:08 AM
CVS Healths Pharmacy Services Remain Solid Amid Retail DragCVS Health's Pharmacy Services Remain Solid Amid Retail Drag
www.msn.com - March 21 at 5:53 PM
PerkinElmer (PKI) Stock Rating Lowered by Zacks Investment ResearchPerkinElmer (PKI) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - March 20 at 2:59 PM
BRIEF-Perkinelmer - CEO Robert Friels 2017 Total Compensation Was $11.4 MlnBRIEF-Perkinelmer - CEO Robert Friel's 2017 Total Compensation Was $11.4 Mln
www.reuters.com - March 15 at 6:31 PM
PerkinElmer, Inc. (PKI) Expected to Post Quarterly Sales of $615.81 MillionPerkinElmer, Inc. (PKI) Expected to Post Quarterly Sales of $615.81 Million
www.americanbankingnews.com - March 15 at 4:58 AM
$0.62 Earnings Per Share Expected for PerkinElmer, Inc. (PKI) This Quarter$0.62 Earnings Per Share Expected for PerkinElmer, Inc. (PKI) This Quarter
www.americanbankingnews.com - March 13 at 3:26 PM
PerkinElmer, Inc. (PKI) Given Consensus Rating of "Hold" by BrokeragesPerkinElmer, Inc. (PKI) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - March 7 at 2:08 PM
Frank Anders Wilson Sells 103,656 Shares of PerkinElmer, Inc. (PKI) StockFrank Anders Wilson Sells 103,656 Shares of PerkinElmer, Inc. (PKI) Stock
www.americanbankingnews.com - March 6 at 6:14 PM
PerkinElmer, Inc. (PKI) Stake Decreased by Wells Fargo & Company MNPerkinElmer, Inc. (PKI) Stake Decreased by Wells Fargo & Company MN
www.americanbankingnews.com - March 6 at 3:08 PM
PerkinElmer, Inc. (PKI) Position Increased by The Manufacturers Life Insurance Company PerkinElmer, Inc. (PKI) Position Increased by The Manufacturers Life Insurance Company
www.americanbankingnews.com - March 5 at 3:27 PM
PerkinElmer, Inc. (PKI) Shares Bought by State of Wisconsin Investment BoardPerkinElmer, Inc. (PKI) Shares Bought by State of Wisconsin Investment Board
www.americanbankingnews.com - March 4 at 9:32 AM
Bank of New York Mellon Corp Acquires 74,735 Shares of PerkinElmer, Inc. (PKI)Bank of New York Mellon Corp Acquires 74,735 Shares of PerkinElmer, Inc. (PKI)
www.americanbankingnews.com - March 4 at 4:45 AM
W. E. Donoghue & Co. LLC Buys New Holdings in PerkinElmer, Inc. (PKI)W. E. Donoghue & Co. LLC Buys New Holdings in PerkinElmer, Inc. (PKI)
www.americanbankingnews.com - March 3 at 4:22 PM
WINTON GROUP Ltd Has $12.60 Million Position in PerkinElmer, Inc. (PKI)WINTON GROUP Ltd Has $12.60 Million Position in PerkinElmer, Inc. (PKI)
www.americanbankingnews.com - March 3 at 2:58 PM
BlackRock Inc. Acquires 195,851 Shares of PerkinElmer, Inc. (PKI)BlackRock Inc. Acquires 195,851 Shares of PerkinElmer, Inc. (PKI)
www.americanbankingnews.com - March 3 at 4:46 AM
DENTSPLY (XRAY) Earnings and Revenues Beat Estimates in Q4DENTSPLY (XRAY) Earnings and Revenues Beat Estimates in Q4
finance.yahoo.com - March 2 at 5:52 PM
Impax Asset Management LTD Has $55.01 Million Position in PerkinElmer, Inc. (PKI)Impax Asset Management LTD Has $55.01 Million Position in PerkinElmer, Inc. (PKI)
www.americanbankingnews.com - March 1 at 5:14 PM
PerkinElmer Inc (PKI) Files 10-K for the Fiscal Year Ended on December 31, 2017PerkinElmer Inc (PKI) Files 10-K for the Fiscal Year Ended on December 31, 2017
finance.yahoo.com - February 28 at 8:00 AM
PerkinElmer to Present at Cowen and Company 38th Annual Health Care ConferencePerkinElmer to Present at Cowen and Company 38th Annual Health Care Conference
finance.yahoo.com - February 28 at 8:00 AM

SEC Filings

PerkinElmer (NYSE:PKI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

PerkinElmer (NYSE:PKI) Income Statement, Balance Sheet and Cash Flow Statement

Chart

PerkinElmer (NYSE PKI) Stock Chart for Saturday, April, 21, 2018

Loading chart…

This page was last updated on 4/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.